|  Help  |  About  |  Contact Us

Publication : Targeting Platelet-Derived Growth Factor Receptor β(+) Scaffold Formation Inhibits Choroidal Neovascularization.

First Author  Strittmatter K Year  2016
Journal  Am J Pathol Volume  186
Issue  7 Pages  1890-9
PubMed ID  27338108 Mgi Jnum  J:234267
Mgi Id  MGI:5789657 Doi  10.1016/j.ajpath.2016.02.018
Citation  Strittmatter K, et al. (2016) Targeting Platelet-Derived Growth Factor Receptor beta(+) Scaffold Formation Inhibits Choroidal Neovascularization. Am J Pathol 186(7):1890-9
abstractText  Neovascular age-related macular degeneration is among the most common causes of irreversible blindness and manifests with choroidal neovascularization (CNV). Anti-vascular endothelial growth factor-A therapies are only partially effective and their chronic administration may impair functions of the choriocapillaris and retina. Thus, novel therapeutic targets are needed urgently. We have observed in a laser-induced model of CNV that a platelet-derived growth factor receptor beta positive (PDGFRbeta(+)) scaffold is formed before infiltration of neovessels into this scaffold to form CNV lesions, and that this scaffold limits the extent of neovascularization. Based on these observations we hypothesized that ablation of proliferating PDGFRbeta(+) cells to prevent the formation of this scaffold might inhibit CNV growth and present a novel therapeutic approach for neovascular age-related macular degeneration. To test this hypothesis we targeted proliferating PDGFRbeta(+) cells through independent distinct approaches after laser injury: i) by using an inducible genetic model to inhibit specifically proliferating PDGFRbeta(+) cells, ii) by treating mice with a neutralizing anti-PDGFRbeta antibody, iii) by administering an anti-PDGF-AB/BB aptamer, and iv) by using small chemical inhibitor approaches. The results show that therapeutic targeting of proliferating PDGFRbeta(+) cells potently inhibits the formation of the pericyte-like scaffold, with concomitant attenuation of CNV. Moreover, we show that early inhibition of PDGFRbeta(+) cell proliferation before neovessel formation is sufficient to inhibit scaffold formation and neovascularization.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

1 Bio Entities

0 Expression